Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Open Forum Infectious Diseases|December 25, 2018
Time for Precision: A World Without Susceptibility BreakpointsJustin C Bader, Elizabeth A Lakota, David R Andes, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapyJ K Thomas, A Forrest, S M Bhavnani, et al.
The Quarterly Journal of Medicine|January 1, 1991
Large granular T lymphocytes, neutropenia and polyarthropathy: an underdiagnosed syndrome?N Snowden, M Bhavnani, D R Swinson, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body SizesElizabeth A Lakota, Cornelia B Landersdorfer, Li Zhang, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statisticsPaul G Ambrose, Jeffrey P Hammel, Sujata M Bhavnani, et al.
Leukemia Research|January 1, 1988
Aplastic anaemia incidence in parts of the United Kingdom in 1985R A Cartwright, P A McKinney, L Williams, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2013
Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimizationDavid R Andes, Daniel K Reynolds, Scott A Van Wart, et al.
Clinical and Experimental Immunology|August 1, 1994
Serum soluble CD23 in patients with hypogammaglobulinaemiaA S Bansal, M R Haeney, S Cochrane, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2023
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil HydrobromideH Ganesan, V K Gupta, M C Safir, et al.
Pageof 16